Skip to Content

Drugs with Pharmacogenomic Tests

February 23, 2010

Drug
Atomoxetine HCI (Strattera)

Purpose
ADHD treatment

The Gene Factor
Patients with a mutation in the CYP2D6 gene are at risk of suffering serious liver damage.

Drug
Clopidogrel (Plavix)

Purpose
Prevents heart attacks by inhibiting blood clots

The Gene Factor
A variation of the CYP2C19 gene interferes with the way the drug is metabolized, rendering it ineffective.

Drug
Cetuximab (Erbitux) and Panitumumab (Vectibix)

Purpose
Colorectal cancer drug

The Gene Factor
The drugs work only in people whose tumors have a normal KRAS gene.

Drug
Gefitinib (Iressa)

Purpose
Lung cancer drug

The Gene Factor
Works best on people whose tumors have a mutation in the EGFR gene.

Drug
Irinotecan (Camptosar)

Purpose
Colorectal cancer drug

The Gene Factor
People with a genetic variant suffer side effects because they have fewer liver enzymes to break down the drug.

Drug
Tamoxifen (Nolvadex)

Purpose
Breast cancer drug

The Gene Factor
Variations in the CYP2D6 gene can make a person metabolize the drug too quickly or not at all.

Drug
Warfarin (Coumadin)

Purpose
Blood thinner

The Gene Factor
In patients with either or both of two genetic variations, the drug can cause excessive bleeding rather than help prevent blood clots. Genetic testing can reveal the right dose.

Keep Reading

Most Popular

conceptual illustration showing various women's faces being scanned
conceptual illustration showing various women's faces being scanned

A horrifying new AI app swaps women into porn videos with a click

Deepfake researchers have long feared the day this would arrive.

A view of clouds illuminated by sunlight
A view of clouds illuminated by sunlight

We can’t afford to stop solar geoengineering research

It is the wrong time to take this strategy for combating climate change off the table.

Death and Jeff Bezos
Death and Jeff Bezos

Meet Altos Labs, Silicon Valley’s latest wild bet on living forever

Funders of a deep-pocketed new "rejuvenation" startup are said to include Jeff Bezos and Yuri Milner.

new GPT3 is a good student
new GPT3 is a good student

The new version of GPT-3 is much better behaved (and should be less toxic)

OpenAI has trained its flagship language model to follow instructions, making it spit out less unwanted text—but there's still a way to go.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.